{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:28:06Z","timestamp":1790566086725,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Med Imag Rad Onc"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Globally, the research community is coming to realise the need for diversity, equity and inclusion (DEI) amongst research teams and leadership. Diverse teams reduce homogeneous \u2018group think\u2019, propagate innovation, propound support for broader more representative research and facilitate the recruitment of patients from diverse backgrounds. Given the above, this study aims to retrospectively examine the characteristics of chief investigators (CI) and principal investigators (PI) in past and present Australian and New Zealand radiation oncology clinical trials.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data on CI and PI characteristics were attained from the Trans Tasman Radiation Oncology Group (TROG) website as well as archived master database files provided by the TROG Scientific Committee. Data included CI and PI discipline, clinical trial activation date, institution type (private vs. public) and geographical location if in Australia. Australian and New Zealand health practitioner registration agency websites were used to determine the registered sex of the CIs and PIs and their years of experience.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and twenty TROG clinical trials have been initiated by 134 CIs from 1989 to 2022 and 463 TROG clinical trials have been opened by 465 PIs at their respective institutions from 2000 to 2022. Most TROG trial investigators have been radiation oncologists and those with over 10\u2009years of experience. Only one in five trials and one in three trials have been led by female PIs and CIs, respectively. Investigators have largely been affiliated with public institutions, with only one in 100 CIs and one in eight PIs being affiliated with the private sector. TROG members from regional and rural areas in Australia have not been engaged as investigators, with all CIs and most PIs affiliated with metropolitan institutions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study highlights the gaps in diversity amongst CIs and PIs in TROG clinical trials. Further unpacking and understanding of issues related to CI and PI diversity are important to inform initiatives to improve researcher, leadership and patient diversity in future TROG clinical trials.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1754-9485.13564","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T18:20:40Z","timestamp":1689531640000},"page":"703-709","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics of chief investigators and principal investigators in Australian and New Zealand radiation oncology clinical trials"],"prefix":"10.1111","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-5295","authenticated-orcid":false,"given":"Hanh","family":"Nguyen","sequence":"first","affiliation":[{"name":"School of Medicine The University of Notre Dame  Fremantle Western Australia Australia"},{"name":"Genesiscare  Perth Western Australia Australia"},{"name":"Trans Tasman Radiation Oncology Group  New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Trans Tasman Radiation Oncology Group  New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-0150","authenticated-orcid":false,"given":"Puma","family":"Sundaresan","sequence":"additional","affiliation":[{"name":"Trans Tasman Radiation Oncology Group  New South Wales Australia"},{"name":"Sydney West Radiation Oncology Network, WSLHD  Sydney New South Wales Australia"},{"name":"Sydney Medical School The University of Sydney  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,7,16]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"World Health Organisation.International Clinical Trials Registry Platform (ICTRP). [Cited 10 Dec 2021.] Available from URL:https:\/\/www.who.int\/clinical\u2010trials\u2010registry\u2010platform."},{"key":"e_1_2_7_3_1","unstructured":"Australian Clinical Trials Australian Government.Types of clinical trials. [Cited 10 Dec 2021.] Available from URL:https:\/\/www.australianclinicaltrials.gov.au\/types\u2010clinical\u2010trials."},{"key":"e_1_2_7_4_1","unstructured":"NHS Health Research Authority.Roles and responsibilities. [Cited 10 Dec 2021.] Available from URL:https:\/\/www.hra.nhs.uk\/planning\u2010and\u2010improving\u2010research\/research\u2010planning\/roles\u2010and\u2010responsibilities\/#:~:text=of%20the%20regulations.\u2010 Chief%20Investigator%20(CI) or%20Investigator%20may%20be%20used."},{"key":"e_1_2_7_5_1","unstructured":"National Cancer Institute.Principle investigator. [Cited 10 Dec 2021.] Available from URL:https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer\u2010terms\/def\/principal\u2010investigator."},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz198"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/08404704211038232"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079147"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-018-0433-1"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0403723101"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.114295"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.10.043"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz174"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.2485"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E20-09-0575"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.03.022"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-018-05049-5"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33905"},{"key":"e_1_2_7_19_1","unstructured":"US Food & Drug Administration (FDA).2020 Drug trials snapshots summary report.2021. [Cited 10 Dec 2021.] Available from URL:https:\/\/www.fda.gov\/media\/145718\/download."},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu017"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12800"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327481602300404"},{"key":"e_1_2_7_23_1","unstructured":"Australian Burden of Disease Study: impact and causes of illness and death in Australia 2018. Australian Government 2018. [Cited 10 Dec 2021.] Available from URL:https:\/\/www.aihw.gov.au\/getmedia\/5ef18dc9\u2010414f\u20104899\u2010bb35\u201008e239417694\/aihw\u2010bod\u201029.pdf.aspx?inline=true."},{"key":"e_1_2_7_24_1","unstructured":"Australian New Zealand Clinical Trials Registry.Interactive real\u2010time statistics. [Cited 10 Dec 2021.] Available from URL:https:\/\/www.anzctr.org.au\/Stats\/RealTimeStats.aspx."},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1608986"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21324"},{"key":"e_1_2_7_27_1","unstructured":"Trans Tasman Radiation Oncology Group.What we do \u2013 clinical trial management. [Cited 10 Dec 2021.] Available from URL:https:\/\/www.trog.com.au\/What\u2010We\u2010Do."},{"key":"e_1_2_7_28_1","unstructured":"Australian Government Department of Health and Aged Care.Health workforce locator. [Cited 20 Dec 2022.] Available from URL:https:\/\/www.health.gov.au\/resources\/apps\u2010and\u2010tools\/health\u2010workforce\u2010locator\/app."},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedn.2022.08.009"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586\u2010022\u201000875\u20100"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1205"},{"key":"e_1_2_7_32_1","article-title":"Trainee principal investigator could improve recruitment in trauma trials: review of literature and experience from a trauma center","volume":"13","author":"Vas A","year":"2021","journal-title":"Cureus"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7401110"},{"key":"e_1_2_7_34_1","unstructured":"Australian Government Department of Health.Radiation oncology; 2016 factsheet. [Cited 20 Dec 2022.] Available from URL:https:\/\/hwd.health.gov.au\/resources\/publications\/factsheet\u2010mdcl\u2010radiation\u2010oncology\u20102016.pdf."},{"key":"e_1_2_7_35_1","unstructured":"Australian Government Department of Health.Medical oncology; 2016 factsheet. [Cited 20 Dec 2022.] Available from URL:https:\/\/hwd.health.gov.au\/resources\/publications\/factsheet\u2010mdcl\u2010medical\u2010oncology\u20102016.pdf."},{"key":"e_1_2_7_36_1","unstructured":"Australian Bureau of Statistics.Australian social trends April 2013. [Cited 18 Dec 2022.] Available from URL:https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/lookup\/4102.0main+features20april+2013."},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002922"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/1754-9485.13492"},{"key":"e_1_2_7_39_1","unstructured":"Australian Government Australian Institute of Health and Welfare.Radiotherapy in Australia 2018\u201319. [Cited 20 Dec 2022.] Available from URL:https:\/\/www.aihw.gov.au\/getmedia\/6a8f251d\u2010065d\u20104932\u201082ac\u2010ea77fa4b8137\/Radiotherapy\u2010in\u2010Australia\u20102018\u201019.pdf.aspx?inline=true."},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.83227"},{"key":"e_1_2_7_41_1","unstructured":"Targeting Cancer The Royal Australian and New Zealand College of Radiologists.Treatment centres. [Cited 20 Dec 2022.] Available from URL:https:\/\/www.targetingcancer.com.au\/treatment\u2010centres\/."},{"key":"e_1_2_7_42_1","unstructured":"Australian Department of Health and Aged Care.Application process open for $45 million for regional cancer centres. [Cited 18 Dec 2022.] Available from URL:https:\/\/www.health.gov.au\/ministers\/the\u2010hon\u2010greg\u2010hunt\u2010mp\/media\/application\u2010process\u2010open\u2010for\u201045\u2010million\u2010for\u2010regional\u2010cancer\u2010centres."},{"key":"e_1_2_7_43_1","unstructured":"Australian Government Australian Institute of Health and Welfare.Rural and remote health. [Cited 18 Dec 2022.] Available from URL:https:\/\/www.aihw.gov.au\/reports\/rural\u2010remote\u2010australians\/rural\u2010and\u2010remote\u2010health."}],"container-title":["Journal of Medical Imaging and Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1754-9485.13564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T23:55:39Z","timestamp":1710719739000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1754-9485.13564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,16]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1111\/1754-9485.13564"],"URL":"https:\/\/doi.org\/10.1111\/1754-9485.13564","archive":["Portico"],"relation":{},"ISSN":["1754-9477","1754-9485"],"issn-type":[{"value":"1754-9477","type":"print"},{"value":"1754-9485","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,16]]},"assertion":[{"value":"2023-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}